CBP/p300-IN-17 (compound 7) is a potent EP300/CBP HAT inhibitor with IC 50 s of 0.18, 0.69 µM for HAT EP300 and LK2 H3K27, respectively.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Histone Acetyltransferase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.